Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors
T. S. Kickler and J. L. Spivak
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD.
The effect of repeated phlebotomy on serum immunoreactive erythropoietin
levels was studied prospectively in 69 autologous blood donors. At the time
of the initial phlebotomy, 11 men (33%) and two women (6%) were anemic;
during the course of blood donations, anemia (defined as a hematocrit less
than 0.41 for men and less than 0.36 for women) developed in an additional
17 men (71%) and 14 women (45%). Although there was an increase in the
level of serum immunoreactive erythropoietin with successive phlebotomies,
the increase was not substantially out of the normal range. The lack of an
erythropoietic response to repeated phlebotomies in association with the
small increment in the serum erythropoietin level was not due to iron
deficiency, since the level of red-cell free protoporphyrin did not
increase in these patients. We conclude that within the hematocrit range
permissible for autologous blood donation, the degree of anemia experienced
is insufficient to initiate an adequate increase in erythropoietin
production; as a consequence, mild anemia develops in a majority of donors,
and the volume of blood donated is inadequate to meet their operative
needs.
Preoperative Epoetin Alfa in Colorectal Surgery: A Randomized, Controlled Study
Christodoulakis et al.
Ann. Surg. Oncol. 2005;12:718-725.
ABSTRACT
| FULL TEXT
Autologous Blood Transfusion in Radical Hysterectomy With and Without Erythropoietin Therapy
Hyllner et al.
Obstet Gynecol 2002;99:757-762.
ABSTRACT
| FULL TEXT
Erythropoietin, iron, and erythropoiesis
Goodnough et al.
Blood 2000;96:823-833.
ABSTRACT
| FULL TEXT
Preoperative Autologous Donation for Total Joint Arthroplasty. An Analysis of Risk Factors for Allogenic Transfusion
HATZIDAKIS et al.
JBJS 2000;82:89-100.
ABSTRACT
| FULL TEXT
Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Current Options and Approaches for Blood Management in Orthopaedic Surgery*{{dagger}}
KEATING
JBJS 1998;80:750-62.
FULL TEXT
Use of Recombinant Human Erythropoietin Outside the Setting of Uremia
Cazzola et al.
Blood 1997;89:4248-4267.
FULL TEXT
Erythropoietin Therapy
Goodnough et al.
NEJM 1997;336:933-938.
FULL TEXT
Blood Transfusion and Blood Conservation: Cost and Utilization Issues
Goodnough et al.
American Journal of Medical Quality 1994;9:172-183.
ABSTRACT
How Safe Are Transfusions? Measures to Increase Safety
Kickler
J Intensive Care Med 1989;4:93-94.